Same same. No surprising details emerging. At this SP if anyone...

Same same. No surprising details emerging. At this SP if anyone is expecting a home run financial statement then look elsewhere.

EVE "should" roughly break even this quarter, then be cash flow positive sometime by midyear. After that then a de-risk / re-rate should occur and that'll be reflected in a more sustainable SP north of $0.03c is my assumption only. Once THC plants their crops then the structure is in place for larger profits by mid next year IMO.
Base - Jenbrook & potential other EVE investment revenue streams. 
Middle - Meluka
Top - Medical grade cannabis honey / serum.

Throw in a few pump and dumps along the journey and investors buying in at these prices should be able to free carry future holdings fairly easily.

Or it goes horribly wrong and VA is announced and we loose all our investment. 
Gamble responsibly.